Mofebutazone
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384614This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H16N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SPW36WUI5Z, chemically known as 3,5-pyrazolidinedione, 4-butyl-1-phenyl- but generally known as mofebutazone, which bears US NIH Compound Identifier 16639. European Medicines Agency schedules Mofebutazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09033MIG. The term MOFEBUTAZONE is an International Non-Proprietary Name. World Health Organization schedules mofebutazone in its Anatomical Therapeutic Chemical (ATC) Classification. MOFEBUTAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mofebutazone under HS 29331990 and SITC 51571. As of Q4 2014, MOFEBUTAZONE remains the US FDA Preferred Term for this commodity. Mofebutazone bears US NLM identifiers UMLS ID C0066774 and NCI Concept Code C73089. SMILES: O=C1N(NC(=O)C1CCCC)C1CCCCC1.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.